Peter Altmaier (l), Federal Minister of Economics and Technology, and Ulrich Nu'baum (r), State Secretary in the Federal Ministry of Economics, take part in a press conference with Franz-Werner Haas (on screen), CEO of the biotech company Curevac, and the investor Hopp.

GSK, Ger­many push coro­n­avirus-fo­cused mR­NA play­er Cure­Vac's lat­est round to $640M

Af­ter court­ing some high-pro­file in­vestors, Cure­Vac has closed a whop­ping $640 mil­lion (€560 mil­lion) in its lat­est round.

The biotech an­nounced the fi­nanc­ing in a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.